[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-341055-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-341055-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","comprehensive-characterization-of-fidgetin-on-tumor-immune-microenvironment-evaluation-and-immunotherapy-in-human-hepatocellular-carcinoma","Comprehensive characterization of Fidgetin on tumor immune microenvironment evaluation and immunotherapy in human hepatocellular carcinoma","","Downregulation of Fidgetin (FIGN) is associated with tumor growth, yet its role in hepatocellular carcinoma (HCC) has been insufficiently characterized. FIGN expression in HCC tissues is markedly reduced compared with adjacent normal liver. Univariate and multivariate Cox regression show FIGN as an independent prognostic predictor, where higher expression relates to poorer survival. Pathway and immune analyses indicate involvement in immune-related signaling, correlation with immunological scores and immune cells, and links to immune checkpoints and “hot” tumor status. Patients with low FIGN expression respond better to immunotherapy and chemotherapy, supporting biomarker potential for prognosis and treatment guidance.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/comprehensive-characterization-of-fidgetin-on-tumor-immune-microenvironment-evaluation-and-immunotherapy-in-human-hepatocellular-carcinoma/341055/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/comprehensive-characterization-of-fidgetin-on-tumor-immune-microenvironment-evaluation-and-immunotherapy-in-human-hepatocellular-carcinoma/341055.png","ImageObject",300,407,{"name":42,"@type":43},"Olivia Brown","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-26","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How does Fidgetin (FIGN) expression differ between HCC and normal liver tissues?","Question",{"text":63,"@type":64},"FIGN expression in HCC tissues is markedly reduced compared with nearby normal liver tissues.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What is the prognostic value of FIGN in hepatocellular carcinoma?",{"text":68,"@type":64},"Univariate and multivariate Cox regression identify FIGN as an independent predictor of survival outcomes, and higher FIGN expression is associated with worse outcomes.",{"name":70,"@type":61,"acceptedAnswer":71},"How is FIGN linked to immune features and immunotherapy response in HCC?",{"text":72,"@type":64},"FIGN is involved in immune-related pathways and correlates with immunological scores and immune cells, including immune checkpoints and hot tumor status; patients with low FIGN expression show a significant therapeutic response to immunotherapy and chemotherapy.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},341055,1790180080,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":99,"preview_page_count":33,"preview_urls":145},16904993612988,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","[www.aging-us.com](www.aging-us.com) AGING 2024, Vol. 16, No. 5  \nResearch Paper  \nComprehensive characterization of Fidgetin on tumor immune microenvironment evaluation and immunotherapy in human hepatocellular carcinoma  \nLongju Qi1,2,*, Shiyuan Chen1,*, Zehua Liao1, Mengjie Fan1, Jiayi Zhang1, Yuan Gao1, Jiabao Shen1, Yuyu Sun2, Qinghua Wang1  \n1 Laboratory Animal Center, Medical School, Nantong University, Nantong, China  \n2Affiliated Nantong Hospital 3 of Nantong University, Nantong University, Nantong, China  \n*Equal contribution  \nCorrespondence to: Yuyu Sun, Qinghua Wang; email: [sunyuyunt@126.com](sunyuyunt@126.com), [https://orcid.org/0000-0002-1614-6368](https://orcid.org/0000-0002-1614-6368); [wangqh@ntu.edu.cn](wangqh@ntu.edu.cn)  \nKeywords: hepatocellular carcinoma, Fidgetin, immune checkpoint, prognosis, immune infiltration  \nReceived: October 18, 2023 Accepted: January 29, 2024 Published: February 27, 2024  \nCopyright: © 2024 Qi et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  \nABSTRACT  \nMost cancers have a downregulation of Fidgetin (FIGN), which has been linked to tumor growth. However, there aren’t many papers that mention FIGN’s connection to hepatocellular carcinoma (HCC) . Here, FIGN expression in HCC tissues was markedly reduced as compared to nearby normal liver tissues. According to univariate and multivariate Cox regression, it served as an independent predictor of survival outcomes. Patients with high levels of FIGN expression had a worse outcome. FIGN was shown to be engaged in immune-related pathways and to have a positive correlation with immunological score and immune cells according to KEGG pathway analysis. In HCC patients, FIGN was substantially linked with immunological checkpoints and the hot tumor state. Additionally, immunotherapy and chemotherapy showed a significant therapeutic response in HCC patients with low FIGN expression. This research revealed that FIGN expression was tightly related to hepatoma immunity and might be employed as a biomarker to predict patient prognosis and guide medication.  \nINTRODUCTION  \nPrimary liver cancer is the second most prevalent cause of cancer-related death and the sixth most frequent malignant tumor worldwide [1, 2] . Hepatocellular carcinoma (HCC), a tumor generated from theparenchymal cells of the livers, makes up around 80% of the most prevalent histology of liver cancer globally [1] . Asians are responsible for approximately 75% of liver tumor cases worldwide, while China accounts for more than 50% of all liver cancer cases. In Qidong City, China, the age-standardized rate (ASR) per 100,000 people is 77.5 [3] . Due to the liver’s sluggish sensitivity to pain and congestion due to the lack of innervated neurons, it is frequently diagnosed in the middle and late stages when there are no longer any operational  \nindications [4] . Treatment for liver cancer places a significant financial burden on the patient’s family as well as the entire community due to its high morbidity and mortality [5] . Although many therapeutic approaches, including targeted therapy and immunotherapy, have been used to treat liver cancer, the survival rate is still quite poor [6] . Therefore, the need to investigate effective biomarkers for the early detection and prognosis of liver cancer is urgent.  \nThe modulation of tumor immune infiltrates and immunotherapy, particularly in the treatment of hepatocellular carcinoma, is heavily influenced by the tumor microenvironment (TME) [7] . TME, which is characterized by an immunosuppressive milieu and tumor vasculature, is a dynamic network involving  \n4445  \nimmunosuppressive cell subsets, inflammatory factors, and malignant cells [8] . Leaky arteries, central hypoxia, dysregulated ECM remodeling, and tumorinfiltrating immune ","cbCais0B545wiEWu","https://ap.wps.com/l/cbCais0B545wiEWu","pdf",5743034,24,"English","# Abstract\n# Introduction\n## Burden and need for biomarkers in hepatocellular carcinoma\n## Tumor microenvironment and immunotherapy response\n## Role and biology of Fidgetin (FIGN)\n# (Manuscript continues)","[{\"question\":\"How does Fidgetin (FIGN) expression differ between HCC and normal liver tissues?\",\"answer\":\"FIGN expression in HCC tissues is markedly reduced compared with nearby normal liver tissues.\"},{\"question\":\"What is the prognostic value of FIGN in hepatocellular carcinoma?\",\"answer\":\"Univariate and multivariate Cox regression identify FIGN as an independent predictor of survival outcomes, and higher FIGN expression is associated with worse outcomes.\"},{\"question\":\"How is FIGN linked to immune features and immunotherapy response in HCC?\",\"answer\":\"FIGN is involved in immune-related pathways and correlates with immunological scores and immune cells, including immune checkpoints and hot tumor status; patients with low FIGN expression show a significant therapeutic response to immunotherapy and chemotherapy.\"}]","Comprehensive characterization of Fidgetin on tumor immune microenvironment evaluation and immunotherapy in human hepatocellular carcinoma | PDF",1790040109,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e46ea81ec9bcd49e34dcf4772fe9df02.webp",983,1272,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f8fa7ca207dc764913f6127c3ead98a3.webp",982,1270,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/16724463a192b1386dcb5e33214d39f8.webp",981,1269,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0658dc7679fe6ce6485a1410ff707aa3.webp",980,1268]